Literature DB >> 21708085

Boston type 1 keratoprosthesis: the CHUM experience.

Marie-Claude Robert1, Mona Harissi-Dagher.   

Abstract

OBJECTIVE: To describe the characteristics, indications, complications, and outcomes of the patients who underwent Boston type 1 keratoprosthesis (KPro) surgery at the Université de Montréal affiliated Notre-Dame Hospital.
DESIGN: Retrospective case series. PARTICIPANTS: Forty-seven eyes of 43 patients who underwent KPro surgery.
METHODS: The charts of all patients who underwent KPro surgery at Notre-Dame Hospital between October 2008 and February 2010 were retrospectively reviewed. Preoperative, intraoperative, and postoperative parameters were collected and analyzed.
RESULTS: The indication for Boston type 1 KPro was corneal graft failure in 27 eyes; 20 eyes had KPro as a primary procedure. Preoperative diagnoses included aniridia (34%), mechanical trauma (11%), infections (9%), surgery-related bullous keratopathy (9%), chemical burns (9%), corneal dystrophies (9%), and Stevens-Johnson syndrome (2%). A known history of glaucoma was present in 36 eyes (77%). Median preoperative best-corrected visual acuity (BCVA) was hand motion (range, 20/100 to light perception). The assembly of the KPro and surgery were uneventful in all cases. Mean follow-up was 10±5 months. MedianBCVA at last follow-up was 20/150 (range, 20/30 to no light perception). The device retention rate was 100% at the end of the follow-up period. Postoperative complications included retroprosthetic membrane in 12 eyes (26%) and glaucoma progression in 11 eyes (23%).
CONCLUSIONS: Our study demonstrates an excellent retention rate of the Boston type 1 KPro and an improvement of BCVA in the majority of patients. Many patients undergoing KPro surgery have ocular comorbidities that require ongoing care to prevent further vision loss following KPro surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708085     DOI: 10.3129/i10-103

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  11 in total

1.  [Boston-keratoprosthesis : Preliminary experiences in 13 high-risk eyes from the Department of Ophthalmology of the University of Cologne].

Authors:  F Schaub; D Hos; F Bucher; S Siebelmann; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2016-06       Impact factor: 1.059

2.  Boston type 1 keratoprosthesis for failed keratoplasty.

Authors:  Jonathan L Hager; David L Phillips; Kenneth M Goins; Anna S Kitzmann; Mark A Greiner; Alex W Cohen; Jeffrey D Welder; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2015-05-16       Impact factor: 2.031

3.  Boston Keratoprosthesis: expanding the boundaries.

Authors:  Mona Harissi-Dagher
Journal:  Digit J Ophthalmol       Date:  2011-11-03

4.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Masako Chen; Sueko M Ng; Esen K Akpek; Sumayya Ahmad
Journal:  Cochrane Database Syst Rev       Date:  2020-05-13

5.  Tracking the evolution of crossmodal plasticity and visual functions before and after sight restoration.

Authors:  Giulia Dormal; Franco Lepore; Mona Harissi-Dagher; Geneviève Albouy; Armando Bertone; Bruno Rossion; Olivier Collignon
Journal:  J Neurophysiol       Date:  2014-12-17       Impact factor: 2.714

Review 6.  Artificial corneas versus donor corneas for repeat corneal transplants.

Authors:  Esen K Akpek; Majed Alkharashi; Frank S Hwang; Sueko M Ng; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2014-11-05

7.  Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.

Authors:  Mohsin H Ali; Mark S Dikopf; Anthony G Finder; Ahmad A Aref; Thasarat Vajaranant; Jose de la Cruz; Maria Soledad Cortina
Journal:  Cornea       Date:  2018-05       Impact factor: 2.651

8.  Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization.

Authors:  Lee Kiang; Mark I Rosenblatt; Rachel Sartaj; Ana G Alzaga Fernandez; Szilard Kiss; Nathan M Radcliffe; Donald J D'Amico; Kimberly C Sippel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-28       Impact factor: 3.117

9.  Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study.

Authors:  Kai B Kang; Faris I Karas; Ruju Rai; Joelle A Hallak; Joann J Kang; Jose de la Cruz; Maria S Cortina
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 10.  Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review.

Authors:  Khalid Al Arfaj
Journal:  Saudi J Ophthalmol       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.